- George W. Bush to embattled Alabama kicker: You will be stronger
- Megachurch pastor with ties to Obama commits suicide
- WaPo to readers: Send us your ‘gun violence’ stories for Sandy Hook anniversary
- U.S. threatens Ukraine with sanctions over dispatch of riot police
- Canada doing away with door-to-door mail delivery by 2018
- NSA chief defends phone spying: ‘There is no other way’
- Hawaii Health Department head killed in plane crash
- Colorado school drops sexual harassment label on boy who kissed girl’s hand
- Australia court strikes down 5-day-old, gay-marriage law
- Fake interpreter at Mandela service: ‘Sorry,’ I have schizophrenia
FDA may let patients buy drugs without prescriptions
Move would increase patients’ out-of-pocket costs
Question of the Day
In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.
The FDA says over-the-counter distribution would let patients get drugs for many common conditions without the time and expense of visiting a doctor, but medical providers call the change medically unsound and note that it also may mean that insurance no longer will pay for the drugs.
“The problem is medicine is just not that simple,” said Dr. Matthew Mintz, an internist at George Washington University Hospital. “You can’t just follow rules and weigh all the pros and cons. It needs to be individualized.”
Under the changes that the agency is considering, patients could diagnose their ailments by answering questions online or at a pharmacy kiosk in order to buy current prescription-only drugs for conditions such as high cholesterol, certain infections, migraine headaches, asthma or allergies.
By removing the prescription requirement from popular drugs, the Obama administration could ease financial pressures on the overburdened Medicare system by paying for fewer doctor visits and possibly opening the door to make seniors pay a larger share of the cost of their medications.
The change could have mixed results for non-Medicare patients. Although they may not have to visit a doctor as often, they could have to dish out more money for medications because most insurance companies don’t cover over-the-counter drugs.
“We would expect that out-of-pocket costs for insured individuals, including those covered by Medicare, would be increased for drugs that are switched from prescription to OTC status,” said Dr. Sandra Adamson Fryhofer, who testified last month on behalf of the American Medical Association in an FDA-held public hearing.
Pharmacists and doctors have lined up on opposite sides of the issue. Often trying to combat a public perception that downplays their medical training, pharmacists embrace the notion that they should be able to dole out medication for patients’ chronic conditions without making them go through a doctor.
“We think it’s a great development for everybody — for pharmacists, for patients and the whole health care system,” said Brian Gallagher, a lobbyist for the American Pharmacists Association. “The way we look at it is there are a lot of people out there with chronic conditions that are undertreated and this would enable the pharmacists to redirect these undertreated people back into the health care system.”
Medical providers urged caution, saying the government should not try to cut health care costs by cutting out doctors.
“What the government via the FDA has decided to do is just bypass the expensive doctor and to satisfy some safety concerns of letting people just pick out their medications is make sure they have to get counsel by the pharmacists,” Dr. Mintz said. “I believe there is value to using pharmacists, but not at the expense of primary care.”
“The FDA has not offered any evidence establishing that it is safe, or patient outcomes are improved, when patients with hypertension, [high cholesterol], asthma or migraine headaches self-diagnose and manage these (or other) serious chronic medical conditions on their own,” she said.
Comments on the proposal are due by May 7.
FDA spokeswoman Erica Jefferson said the agency will issue a decision sometime after that but didn’t offer a more specific time frame.
“The agency is still reviewing the public comments and will make a determination on the best path forward once this has been completed,” she said.
© Copyright 2013 The Washington Times, LLC. Click here for reprint permission.
About the Author
- A familiar fading feeling for McMahon in Connecticut
- Romney’s bid to undo health law faces hurdles
- Hill GOP presses Medicare probe
- Romney, Obama advisors butt heads over binders, Big Bird and “Romnesia”
- Outsiders abide by rules in Brown-Warren race
Latest Blog Entries
By Matt Kibbe
The short-term deal will assure long-term overspending
- NAPOLITANO: A conspiracy so vast
- All-out war breaks out in GOP over budget pact
- Washington Post to readers: Send us your gun violence stories for Sandy Hook anniversary
- Biden guarantees victory on immigration reform
- MALCOLM/REIMER: Over-criminalization undermines respect for legal system
- Study IDs reasons for late-term abortions
- Obama takes 'selfie' at Mandela's funeral service
- Rand Paul: Budget deal 'shameful,' 'huge mistake'
- Colorado school drops sexual harassment label on boy who kissed girl's hand
- Teen thugs in D.C. run wild -- even while wearing GPS ankle bracelets
Independent voices from the The Washington Times Communities
All of the world’s problems, solved on your back porch
Al Maurer provides a common sense, conservatarian, Constitutional conservative perspective from the battleground state of Colorado
Interviews and show reviews from the Los Angeles punk scene past and present. Los Angeles has always been rich in punk rock talent since punk rock was born.
Buzz on Bees is a column promoting the love and life of God’s greatest pollinators on earth: The Honeybee
Extraordinary day at Redskins Park
White House pets gone wild!
Let it snow